SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-022537
Filing Date
2020-11-04
Accepted
2020-11-04 16:32:23
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20200930_10q.htm 10-Q 673417
2 EXHIBIT 4.1 ex_210694.htm EX-4.1 74193
3 EXHIBIT 31.1 ex_210690.htm EX-31.1 15069
4 EXHIBIT 31.2 ex_210691.htm EX-31.2 15402
5 EXHIBIT 32.1 ex_210692.htm EX-32.1 7550
6 EXHIBIT 32.2 ex_210693.htm EX-32.2 7932
13 logo.jpg GRAPHIC 28847
  Complete submission text file 0001437749-20-022537.txt   3814959

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dmac-20200930.xml EX-101.INS 697302
8 XBRL TAXONOMY EXTENSION SCHEMA dmac-20200930.xsd EX-101.SCH 46631
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20200930_cal.xml EX-101.CAL 32356
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20200930_def.xml EX-101.DEF 289159
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20200930_lab.xml EX-101.LAB 240365
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20200930_pre.xml EX-101.PRE 312543
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 201287156
SIC: 2834 Pharmaceutical Preparations